Washington, DC (April 1, 2009) – A faculty of internationally-renowned osteoporosis experts are gathering today to share the latest clinically-relevant information on osteoporosis prevention, diagnosis and treatment at the National Osteoporosis Foundation’s (NOF) 8th International Symposium on Osteoporosis (ISO8): “Translating Research Into Clinical Practice,” April 1-5, 2009 at the Marriott Wardman Park Hotel in Washington, DC Held once every two years, ISO8 aims to bridge the gap between osteoporosis research and its application in clinical practice.
Conference presenters will focus on the role of common, chronic diseases in the incidence of osteoporosis, including diabetes, depression, stroke and Parkinson’s disease, as well as NOF’s recently released Clinician’s Guide to Prevention and Treatment and the World Health Organization’s FRAX® tool, which aid clinicians in evaluating a patient’s risk for fracture. Additionally, presenters will address emerging therapies and diagnostic techniques; skeletal development across the lifespan; and clinical guidelines for diagnosing and treating men with osteoporosis.
Peter Cavanagh, PhD, University of Washington, professor of orthopaedics and sports medicine, will present a keynote address from his study in which 22 volunteers remain in bed simulating the weightlessness of spaceflight. The study findings offer for the first time a way to prevent bone loss in a specific region of the hip.
“Osteoporosis and low bone mass are conditions that increase the risk of serious and disabling fractures, affecting 44 million Americans or 55 percent of the population age 50 and older,” said Robert Recker, MD, president of NOF. “Despite all we know about osteoporosis, it remains a disease that is significantly under-diagnosed and under-treated. The information shared at ISO8 will provide clinicians with the most current information and data to prevent osteoporosis, identify people at risk more accurately, and properly diagnose and treat those with the disease.”
Another major topic of discussion will be the National Action Plan for Bone Health:Recommendations from the Summit for a National Action Plan for Bone Health. “Osteoporosis often goes undetected in patients until a fracture occurs, leading to severe physical, social, functional and psychological consequences,” said Leo Schargorodski, executive director of NOF. “This report serves as a blueprint for public health action to reduce the burden of osteoporosis in the U.S.”
According to NOF prevalence estimates and reinforced in Bone Health and Osteoporosis: A Report of the Surgeon General, osteoporosis is a major public health threat for the nation. In the U.S. today, one in two women and one in four men will break a bone due to osteoporosis in their remaining lifetime.
# # #
Celebrating its 25th anniversary, the National Osteoporosis Foundation is the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health. Our mission is to prevent osteoporosis and related fractures, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis, and to find a cure through programs of awareness, advocacy, patient and health professional education, and research. For more information, contact NOF online at www.nof.org or by telephone at (800) 223-9994.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.